Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-10-26

Clinical Trial Update: Evaluation of PHP-201 Ophthalmic Solution in Patients With Normal Tension Glaucoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating PHP-201 ophthalmic solution in normal tension glaucoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PHP-201

Snippet

Sponsor: pH Pharma | Conditions: Normal Tension Glaucoma | Phase 2 | Status: COMPLETED